The (Re-) Emergence of the Age of Enablement: Amgen v. Sanofi On May 18, 2023, biotech innovation suffered at least a temporary setback in Amgen v Sanofi in which a unanimous Supreme Court affirmed the rulings of the district court and the Court of Appeals for the Federal Circuit holding that Amgen’s challenged patent …
The (Re-) Emergence of the Age of Enablement: Amgen v. Sanofi Read More »
The (Re-) Emergence of the Age of Enablement: Amgen v. Sanofi On May 18, 2023, biotech innovation suffered at least a temporary setback in Amgen v Sanofi in which a unanimous Supreme Court affirmed the rulings of the district court and the Court of Appeals for the Federal Circuit holding that Amgen’s challenged patent …
The (Re-) Emergence of the Age of Enablement: Amgen v. Sanofi Read More »
Assignor Estoppel: Protecting Your Patent Rights The centuries-old common law doctrine of assignor estoppel is intended to prevent an inventor from making inconsistent representations about a patent’s validity by first warranting the patent is valid when assigning rights, but then later claiming the patent is invalid. In 2021, while upholding the doctrine in Hologic …
Assignor Estoppel: Protecting Your Patent Rights Read More »
